Related topics: women , cancer cells
Breast cancer
hideBreast cancer is a cancer that starts in the breast, usually in the inner lining of the milk ducts or lobules. There are different types of breast cancer, with different stages (spread), aggressiveness, and genetic makeup. With best treatment, 10-year disease-free survival varies from 98% to 10%. Treatment is selected from surgery, drugs (chemotherapy), and radiation. .
In the United States, there were 216,000 cases of invasive breast cancer and 40,000 deaths in 2004. Worldwide, breast cancer is the second most common type of cancer after lung cancer (10.4% of all cancer incidence, both sexes counted) and the fifth most common cause of cancer death. In 2004, breast cancer caused 519,000 deaths worldwide (7% of cancer deaths; almost 1% of all deaths).
Breast cancer is about 100 times as frequent among women as among men, but survival rates are equal in both sexes.
For more information about Breast cancer, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with breast cancer
Poor being turned away from free cancer screenings
Dec 13, 2009 |
3 / 5 (2) |
3
(AP) -- As the economy falters and more people go without health insurance, low-income women in at least 20 states are being turned away or put on long waiting lists for free cancer screenings, according ...
Plastics component affects intestine: study
Dec 14, 2009 |
5 / 5 (7) |
1
The chemical Bisphenol A used in plastic containers and drinks cans has been shown for the first time to affect the functioning of the intestines, according to a French study published Monday.
Nanoprobes hit targets in tumors, could lessen chemo side effects
Nanotechnology / Bio & Medicine
Dec 14, 2009 |
5 / 5 (1) |
0
(PhysOrg.com) -- Tiny nanoprobes have shown to be effective in delivering cancer drugs more directly to tumor cells - mitigating the damage to nearby healthy cells - and Purdue University research has shown that the nanoprobes ...
Landmark study confirms chemotherapy benefit in breast cancer patients
Dec 11, 2009 |
not rated yet |
0
Chemotherapy generally improves survival in postmenopausal breast cancer patients, according to a landmark study led by Dr. Kathy Albain of Loyola University Health System.
Decline of hormone therapy decreases breast cancer cases, analysis finds
Dec 09, 2009 |
2.5 / 5 (4) |
0
The declining use of hormone therapy among women has led to 6,000 fewer invasive breast cancer cases a year, according to an analysis by researchers at the University of Wisconsin-Madison. The research quantifies and advances ...
DC-SCRIPT found to have prognostic value in breast cancer
Dec 14, 2009 |
not rated yet |
0
DC-SCRIPT, or dendritic cell-specific transcript, is a key regulator of nuclear receptor activity that may have prognostic value in breast cancer, according to a new study published online December 14 in the Journal of th ...
Study questions true favorability of rare breast cancer type
Dec 12, 2009 |
not rated yet |
0
In a large review of breast cancer patients with mucinous carcinoma, researchers at The University of Texas M. D. Anderson Cancer Center have identified an association between this rare type of breast cancer long-associated ...
Study finds racial disparities exist in radiation therapy rates for early stage breast cancer
Dec 14, 2009 |
not rated yet |
0
Black women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M. D. Anderson ...
Novel drug combo improves breast cancer survival
Dec 11, 2009 |
not rated yet |
0
(AP) -- Some women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women who had stopped responding to other ...
Most Oncologists Feel New Genetic Test for Tamoxifen Sensitivity Not Ready for the Clinic
Dec 11, 2009 |
not rated yet |
0
(PhysOrg.com) -- Despite commercial availability and direct to consumer marketing of a new genetic test designed to reveal a breast cancer patient’s sensitivity to tamoxifen, most physicians in the U.S. are not currently ...
Clinical trial advances new approach to re-sensitizing breast cancer
Dec 13, 2009 |
not rated yet |
0
A new drug cocktail might be the right mix to fight breast cancer after it becomes resistant to standard therapy. Details of a new study supporting this approach suggest it's possible to re-sensitize tumors thus allowing ...
Anti-estrogens may offer protection against lung cancer mortality
Dec 11, 2009 |
not rated yet |
0
Anti-estrogens as therapy for breast cancer may also reduce the risk of death from lung cancer, according to study results presented at the CTRC-AACR San Antonio Breast Cancer Symposium, held here Dec. 9-13, 2009.
Obesity linked with poorer breast cancer outcomes
Dec 10, 2009 |
not rated yet |
0
Breast cancer patients with a high body mass index (BMI) have a poorer cancer prognosis later in life. Specifically, their treatment effect does not last as long and their risk of death increases.
Disagreement Over Mammography Task Force Study
Dec 09, 2009 |
not rated yet |
0
When a government-appointed panel of experts released new guidelines last month calling for fewer routine mammograms, they were met with public confusion, political outrage, and a media storm that left women ...
Potential new 'twist' in breast cancer detection
Dec 04, 2009 |
not rated yet |
1
Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accurately distinguish stem cells ...
